| Tap a line for its trend | Currentlast close | FY24Mar 2024 | FY23Mar 2023 |
|---|
| 1.4 | 1.4 | — | |
| 208 | 208 | 107 | |
| — | +94.0% | — | |
| 4.6 | 4.6 | 7.2 | |
| 2.2% | 2.2% | 6.7% | |
| 4.0 | 4.0 | 6.5 | |
| 11.2 | 11.2 | 6.7 | |
| 5.4% | 5.4% | 6.2% | |
| 21.8 | 21.8 | −2.3 | |
| −0.4 | −0.4 | −50.5 | |
| 21.4 | 21.4 | −52.8 | |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | Current last close | |
|---|---|---|---|---|
| - Cash, Equiv & ST Investments | — | 1.4 | 1.4 | |
| Revenue | 107.1 | 207.8 | 207.8 | |
| Growth %, YoY | — | +94.0 | — | |
| EBITDA | 7.2 | 4.6 | 4.6 | |
| Margin % | 6.70 | 2.19 | 2.19 | |
| EBIT | 6.5 | 4.0 | 4.0 | |
| Net Income | 6.7 | 11.2 | 11.2 | |
| Margin % | 6.24 | 5.38 | 5.38 | |
| Cash from Operations | -2.3 | 21.8 | 21.8 | |
| Capital Expenditures | -50.5 | -0.4 | -0.4 | |
| Free Cash Flow | -52.8 | 21.4 | 21.4 | |
Figures from the company's filings with NSE
In FY24 its consolidated net profit was ₹11.2 crore on revenue of ₹208 crore. It had no borrowings on 31 March 2024.
Yes. Dhatre Udyog had no borrowings on 31 March 2024 (consolidated balance sheet), and it held ₹1.4 crore of cash, bank balances and current investments.
Dhatre Udyog's debt-to-equity ratio was 0.00 on 31 March 2024: no borrowings against total equity of ₹70.4 crore.
Dhatre Udyog's net worth — shareholders' equity in its consolidated balance sheet — was ₹70.4 crore on 31 March 2024.
In FY24, Dhatre Udyog generated ₹21.8 crore of cash from operations and spent ₹40 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹21.4 crore. In FY23 it was −₹52.8 crore.
In FY24 (April 2023–March 2024), Dhatre Udyog's consolidated net profit was ₹11.2 crore, up 67.2% from ₹6.7 crore in FY23, on revenue from operations of ₹208 crore (up 94.0%).
From Dhatre Udyog's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.